Creo Medical’s interims show hard work is paying off, says CEO

Creo Medical Group PLC’s (LON:CREO) CEO, Craig Gulliford said that the company’s core products are driving growth and improving results.

There is a clear line to profitability now, he says, highlighting a doubling of patients treated using its endoscopy technology.

A recent acquisition in Europe lays the base for growth here, he adds, while customer demand generally is pulling it increasingly towards the robotic space.

#Creo Medical #AIM #Med-tech

You might like

© 2022 The Latest StockMarket News and Interviews